Skip to main navigation
Skip to search
Skip to main content
University of Limerick Home
Home
Profiles
Research units
Research output
Prizes
Activities
Press/Media
Student theses
Search by expertise, name or affiliation
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
Justin Fortune Creeden
, Ali Sajid Imami
, Hunter M Eby
, Cassidy Gillman
, Kathryn N Becker
, Jim Reigle
, Elissar Andari
, Zhixing K Pan
,
Sinead M O'Donovan
, Robert E McCullumsmith
, Cheryl B McCullumsmith
University of Toledo
University of Toledo College of Medicine and Life Sciences
University of Cincinnati College of Medicine
University of Toledo Medical Center
Department of Neurosciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Infection
100%
Anti-Inflammatory Drug
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Fluoxetine
100%
COVID-19
66%
Interleukin 6
66%
Transcriptomics
33%
Intensive Care Unit
33%
Sepsis
33%
Antiinflammatory Activity
33%
Asthma
33%
Glycoprotein Gp 130
33%
Signal Transduction
33%
Cell Line
33%
Transcription Factors
33%
Cytokine Storm
33%
Interleukin 6 Receptor
33%
Nuclear Factor Kappa B
33%
Antidepressant
33%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Anti-Inflammatory Drug
100%
SARS Coronavirus
100%
Fluoxetine
100%
Coronavirinae
66%
Interleukin 6
66%
Diseases
66%
Antidepressant
33%
Nuclear Factor
33%
Asthma
33%
Antiinflammatory Activity
33%
Glycoprotein Gp 130
33%
Sepsis
33%
Transcription Factors
33%
Cytokine Storm
33%
Interleukin 6 Receptor
33%